Literature DB >> 18791665

Protective effect of bioactive ceramics on liver injury: regulation of pro-inflammatory cytokins expression.

Tae-Sung Lee1, Kwan-Kyu Park, Kyung-Hyun Kim, Young-Ae Chu, Jae-Pil Jeon, Meeyul Hwang.   

Abstract

AIM OF STUDY: A bioactive ceramics has been reported to regulate the expression of inflammatory cytokines in macrophage cells activated by lipopolysaccharides (LPS). In present study, we investigated the anti-inflammatory effect of bioactive ceramics using liver injury model in mouse.
MATERIALS AND METHODS: Mice were divided into three groups: Normal group, LPS group (LPS and no ceramics treatment), Ceramics group (LPS and ceramics treatment).
RESULTS: LPS administration induced the increase of plasma aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in mouse. The losses of cytoplasm of hepatocytes due to LPS caused the increase of AST and ALT in mouse plasma. In Ceramics group, however, the concentration of AST and ALT were much lower than LPS group until 6 weeks. And the losses of cytoplasm were rarely seen in Ceramics group. RT-PCR results showed that the decrease of proinflammatory cytokines such as IL-1beta and IL-6 was observed in Ceramics group. Moreover, TGF-beta1 and VEGF expression was increased in Ceramics group.
CONCLUSION: Bioactive ceramics effectively protected endotoxin-induced liver injury by attenuation of inflammatory processes in mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18791665     DOI: 10.1007/s10856-008-3576-1

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  11 in total

Review 1.  Third-generation biomedical materials.

Authors:  Larry L Hench; Julia M Polak
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

Review 2.  Are nitric oxide synthases new players in the pathophysiology of fulminant hepatic failure?

Authors:  Richard Moreau
Journal:  J Hepatol       Date:  2002-11       Impact factor: 25.083

3.  SPA therapy in fibromyalgia: a randomised controlled clinic study.

Authors:  Arif Dönmez; M Zeki Karagülle; Nuran Tercan; Mustafa Dinler; Halim Işsever; Mine Karagülle; Mustafa Turan
Journal:  Rheumatol Int       Date:  2005-06-17       Impact factor: 2.631

4.  Direct chemical bond of bioactive glass-ceramic materials to bone and muscle.

Authors:  L L Hench; H A Paschall
Journal:  J Biomed Mater Res       Date:  1973

Review 5.  Bioactive ceramics.

Authors:  L L Hench
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

6.  Surface-active biomaterials.

Authors:  L L Hench; J Wilson
Journal:  Science       Date:  1984-11-09       Impact factor: 47.728

7.  Silica-ceramic suppresses the expression of proinflammatory cytokines induced by lipopolysaccharide in macrophages.

Authors:  Meeyul Hwang; Kwan-Kyu Park; Young-Chae Chang; Young-Ae Choo; Jae-Pil Jeon; Im-Hee Shin; Tae-Sung Lee
Journal:  J Biomed Mater Res A       Date:  2007-03-01       Impact factor: 4.396

8.  Mice lacking inducible nitric oxide synthase show strong resistance to anti-Fas antibody-induced fulminant hepatitis.

Authors:  BaoJun Chang; Manabu Nishikawa; Eisuke Sato; Masayasu Inoue
Journal:  Arch Biochem Biophys       Date:  2003-03-01       Impact factor: 4.013

Review 9.  CD14 and other recognition molecules for lipopolysaccharide: a review.

Authors:  T L Kielian; F Blecha
Journal:  Immunopharmacology       Date:  1995-04

10.  Effect of ceramic-impregnated "thermoflow" gloves on patients with Raynaud's syndrome: randomized, placebo-controlled study.

Authors:  Gordon D Ko; David Berbrayer
Journal:  Altern Med Rev       Date:  2002-08
View more
  1 in total

1.  Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients.

Authors:  Takuya Iwamoto; Shuji Terai; Yuko Mizunaga; Naoki Yamamoto; Kaoru Omori; Koichi Uchida; Takahiro Yamasaki; Yasuhiko Fujii; Hiroshi Nishina; Isao Sakaida
Journal:  J Gastroenterol       Date:  2011-11-09       Impact factor: 7.527

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.